Patients on GnRH agonist therapy (Lupron, Orilissa) who add tirzepatide gain 60% less weight and maintain better insulin sensitivity compared to hormonal therapy alone
The effect of 2.4 mg once-weekly injected semaglutide in patients with HFpEF, obesity and T2D is currently investigated in an ongoing trial STEP-HFpEF DM (Semaglutide Treatment Effect in People with obesity and HFpEF and type 2 diabetes) (64, 65)
Our weight loss program in Murrieta, California uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound, and more to help patients lose weight and reach their goals under the guidance of a licensed provider
International shipping isn't offered at this time due to customs and regulatory complexity around research compounds
Overall 10/10 Verified review - view original Verified review - view original Delivery on time